Experienced in Chronic Erosive Gastritis

Raquel S. Del Valle

Oviedo, AS, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Chronic Erosive Gastritis
Oviedo, AS, ES 
OverviewLocationsClinical Research

Overview

Raquel Del Valle practices in Oviedo, Spain. Ms. Del Valle is rated as an Experienced expert by MediFind in the treatment of Chronic Erosive Gastritis. Her top areas of expertise are Aortic Valve Stenosis, Heart Block, Cholecystitis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Her clinical research consists of co-authoring 58 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Chronic Erosive Gastritis.

Gender
Female

Locations

Oviedo, AS, Spain
Other Locations
Madrid, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Dominantly Inherited Alzheimer Network (DIAN)
Dominantly Inherited Alzheimer Network (DIAN)
Enrollment Status: Recruiting
Publish Date: October 28, 2025
Registry of Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis
Registry of Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis
Enrollment Status: Completed
Publish Date: June 24, 2022
Intervention Type: Other
A 6-months Prospective, Multi-center, Double-blind, Placebo-controlled, Randomized, Adaptive-trial-design Study to Evaluate Safety, Tolerability and Exploratory Endpoints of Either Placebo or Two Different Oral Doses of LM11A-31-BHS in Patients With Mild to Moderate Probable Alzheimer's Disease
A 6-months Prospective, Multi-center, Double-blind, Placebo-controlled, Randomized, Adaptive-trial-design Study to Evaluate Safety, Tolerability and Exploratory Endpoints of Either Placebo or Two Different Oral Doses of LM11A-31-BHS in Patients With Mild to Moderate Probable Alzheimer's Disease
Enrollment Status: Completed
Publish Date: September 04, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trial

58 Total Publications

Pacemaker risk stratification in patients with pre-existing right bundle branch block undergoing transcatheter aortic valve replacement.
Pacemaker risk stratification in patients with pre-existing right bundle branch block undergoing transcatheter aortic valve replacement.
Journal: The Canadian journal of cardiology
Published: March 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Del Valle's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile